ALK and lung carcinoma: Despite the development and increased availability of new therapeutic drugs for lung cancer, ALK-targeted drugs show a varied spectrum of drug efficacy and resistance to various mutations, thus leaving lung cancer the leading cause of cancer-related mortality worldwide [10].